Literature DB >> 17368842

Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.

Amélie Roué1, Jack L M Venselaar, Ivaldo H Ferreira, André Bridier, Jan Van Dam.   

Abstract

BACKGROUND AND
PURPOSE: In the framework of an ESTRO ESQUIRE project, the BRAPHYQS Physics Network and the EQUAL-ESTRO laboratory have developed a procedure for checking the absorbed dose to water in the vicinity of HDR or PDR sources using a mailed TLD system. The methodology and the materials used in the procedure are based on the existing EQUAL-ESTRO external radiotherapy dose checks.
MATERIALS AND METHODS: A phantom for TLD postal dose assurance service, adapted to accept catheters from different HDR afterloaders, has been developed. The phantom consists of three PMMA tubes supporting catheters placed at 120 degrees around a central TLD holder. A study on the use of LiF powder type DTL 937 (Philitech) has been performed in order to establish the TLD calibration in dose-to-water at a given distance from (192)Ir source, as well as to determine all correction factors to convert the TLD reading into absorbed dose to water. The dosimetric audit is based on the comparison between the dose to water measured with the TL dosimeter and the dose calculated by the clinical TPS. Results of the audits are classified in four different levels depending on the ratio of the measured dose to the stated dose. The total uncertainty budget in the measurement of the absorbed dose to water using TLD near an (192)Ir HDR source, including TLD reading, correction factors and TLD calibration coefficient, is determined as 3.27% (1s).
RESULTS: To validate the procedures, the external audit was first tested among the members of the BRAPHYQS Network. Since November 2004, the test has been made available for use by all European brachytherapy centres. To date, 11 centres have participated in the checks and the results obtained are very encouraging. Nevertheless, one error detected has shown the usefulness of this audit.
CONCLUSION: A method of absorbed dose to water determination in the vicinity of an (192)Ir brachytherapy source was developed for the purpose of a mailed TL dosimetry system. The accuracy of the procedure was determined. This method allows a check of the whole dosimetry chain for this type of brachytherapy afterloading system and can easily be performed by mail to any institution in the European area and elsewhere. Such an external audit can be an efficient QC method complementary to internal quality control as it can reveal some errors which are not observable by other means.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368842     DOI: 10.1016/j.radonc.2007.02.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  Dosimetric audit in brachytherapy.

Authors:  A L Palmer; D A Bradley; A Nisbet
Journal:  Br J Radiol       Date:  2014-05-06       Impact factor: 3.039

2.  Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Authors:  Catharine H Clark; Edwin G A Aird; Steve Bolton; Elizabeth A Miles; Andrew Nisbet; Julia A D Snaith; Russell A S Thomas; Karen Venables; David I Thwaites
Journal:  Br J Radiol       Date:  2015-09-02       Impact factor: 3.039

3.  Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques.

Authors:  Antony Palmer; David Bradley; Andrew Nisbet
Journal:  J Contemp Brachytherapy       Date:  2012-06-30

4.  Comparison of TLD calibration methods for 192Ir dosimetry.

Authors:  Annette Haworth; Duncan J Butler; Lisa Wilfert; Martin A Ebert; Stephen P Todd; Anna J M Hayton; Tomas Kron
Journal:  J Appl Clin Med Phys       Date:  2013-01-07       Impact factor: 2.102

5.  End-to-end test and MOSFET in vivo skin dosimetry for 192Ir high-dose-rate brachytherapy of chronic psoriasis.

Authors:  Lalida Tuntipumiamorn; Pitchayut Nakkrasae; Sansanee Kongkum; Pittaya Dankulchai
Journal:  J Contemp Brachytherapy       Date:  2019-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.